The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth

SIMPLE SUMMARY: The low survival rate of osteosarcoma (OS) patients underlines the urgency of developing new therapeutic strategies for this disease. In recent years, the important role of Hippo/YAP signaling in cancer has been evaluated, focusing on the possibility of targeting this signaling pathw...

Descripción completa

Detalles Bibliográficos
Autores principales: Morice, Sarah, Mullard, Mathilde, Brion, Regis, Dupuy, Maryne, Renault, Sarah, Tesfaye, Robel, Brounais-Le Royer, Bénédicte, Ory, Benjamin, Redini, Françoise, Verrecchia, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766439/
https://www.ncbi.nlm.nih.gov/pubmed/33419295
http://dx.doi.org/10.3390/cancers12123847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766439/
https://www.ncbi.nlm.nih.gov/pubmed/33419295
http://dx.doi.org/10.3390/cancers12123847

Ejemplares similares